Compared to control media (CTRL) and fibroblast conditioned media without TGFβ pretreatment (CM), TGFβ‐CM activated STAT3 in cancer cells, an effect that was efficiently inhibited by 2G8 treatment of the fibroblasts (TGFβ‐CM + 2G8). The gene discussed is TGFB1; the disease is cancer.